Antivirals Could Reduce Long COVID Risk and H...

On this episode of Science Quickly, host Rachel Feltman discusses Japan’s half-billion-dollar mission to land on Mars’s lumpy little moon Phobos and catches up on animal behavior, both big and small—from newly discovered cartwheeling snakes to the surprisingly complex vocal reper ...  Show more

Our brains are constantly trying to predict what comes next, but in an increasingly unpredictable world, that mental workload can fuel stress, anxiety and even depression. In this episode of Science Quickly, author Maia Szalavitz explains how the brain processes uncertainty, why ...  Show more

There’s a ton of hoopla over these new coronavirus vaccines. But given that they’ve been produced at warp speed — can we trust them? We also find out what’s going on with “long haulers.” How common is it to be sick for months from Covid-19? Plus, fresh new science about why some ...  Show more

Can people who are vaccinated still carry and transmit the coronavirus to other people? How effective are the vaccines against coronavirus variants? And what's the deal with side effects? In this episode, an excerpt of Maddie's appearance on another NPR podcast, It's Been a Minut ...  Show more

In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical appraisal masters: Dr. Andrew Morris, Dr. Rohit Mohindra and Dr. Justin Morgenstern. What is the evidence for the neutralizing monoclonal antibody medications ...  Show more